Background: This study was designed to investigate the relationship between transient neurological deterioration and changes in cerebral perfusion after superficial temporal artery/middle cerebral artery (STA-MCA) bypass. Methods: Clinical characteristics of the patients with postoperative transient neurological deterioration were analyzed in 120 STA-MCA bypass procedures for ischemic cerebral diseases, such as atherosclerotic disease and moyamoya disease. Serial brain single-photon emission computed tomography (SPECT) was performed on 25 patients before surgery and on the third and tenth postoperative days. The hemispheric perfusion on SPECT was calculated semi-quantitatively using statistical parametric mapping and a probabilistic brain atlas. Results: Among 120 procedures, there were 4 permanent postoperative neurological deficits (3.3%) and 20 postoperative transient neurologic deteriorations with unknown etiology (17%). In 25 patients analyzed for postoperative perfusion changes, cerebral perfusion increased on the third postoperative day and the increased perfusion negatively correlated with preoperative perfusion (correlation coefficient = –0.77; p < 0.001). Temporal changes and the location of transient hyperperfusion on SPECT correlated with the time course and neurological deficits associated with postoperative transient neurological deterioration in 3 patients. Conclusions: Postoperative transient relative hyperperfusion is a common phenomenon and may be one of the causes of postoperative transient neurological deterioration after STA-MCA bypass surgery for ischemic cerebral diseases.

Keywords:
Hyperperfusion, Superficial temporal artery/middle cerebral artery bypass, Brain perfusion SPECT
1.
Chater N, Popp J: Microsurgical vascular bypass for occlusive cerebrovascular disease: review of 100 cases. Surg Neurol 1976;6:115–118.
2.
Heros RC, Scott RM, Kistler JP, Ackerman RH, Conner ES: Temporary neurological deterioration after extracranial-intracranial bypass. Neurosurgery 1984;15:178–185.
3.
Furuya K, Kawahara N, Morita A, Momose T, Aoki S, Kirino T: Focal hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: case report. J Neurosurg 2004;100:128–132.
4.
Kuroda S, Kamiyama H, Abe H, Asaoka K, Mitsumori K: Temporary neurological deterioration caused by hyperperfusion after extracranial-intracranial bypass – case report and study of cerebral hemodynamics. Neurol Med Chir (Tokyo) 1994;34:15–19.
5.
Newell DW, Vilela MD: Superficial temporal artery to middle cerebral artery bypass. Neurosurgery 2004;54:1441–1448, discussion 1448–1449.
6.
Lee HY, Paeng JC, Lee DS, Lee JS, Oh CW, Cho MJ, Chung JK, Lee MC: Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT. J Nucl Med 2004;45:202–206.
7.
Higashi S, Matsuda H, Fujii H, Ito H, Yamashita J: Luxury perfusion syndrome confirmed by sequential studies of regional cerebral blood flow and volume after extracranial to intracranial bypass surgery: case report. Neurosurgery 1989;25:85–89.
8.
Yoshimoto T, Houkin K, Kuroda S, Abe H, Kashiwaba T: Low cerebral blood flow and perfusion reserve induce hyperperfusion after surgical revascularization: case reports and analysis of cerebral hemodynamics. Surg Neurol 1997;48:132–138, discussion 138–139.
9.
Abou-Chebl A, Yadav JS, Reginelli JP, Bajzer C, Bhatt D, Krieger DW: Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol 2004;43:1596–1601.
10.
Ascher E, Markevich N, Schutzer RW, Kallakuri S, Jacob T, Hingorani AP: Cerebral hyperperfusion syndrome after carotid endarterectomy: predictive factors and hemodynamic changes. J Vasc Surg 2003;37:769–777.
11.
Komoribayashi N, Ogasawara K, Kobayashi M, Saitoh H, Terasaki K, Inoue T, Ogawa A: Cerebral hyperperfusion after carotid endarterectomy is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia. J Cereb Blood Flow Metab 2006;26:878–884.
12.
McCabe DJ, Brown MM, Clifton A: Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke 1999;30:2483–2486.
13.
Rubio F, Martinez-Yelamos S, Cardona P, Krupinski J: Carotid endarterectomy: is it still a gold standard? Cerebrovasc Dis 2005;20(suppl 2):119–122.
14.
Ogasawara K, Inoue T, Kobayashi M, Endo H, Yoshida K, Fukuda T, Terasaki K, Ogawa A: Cerebral hyperperfusion following carotid endarterectomy: diagnostic utility of intraoperative transcranial Doppler ultrasonography compared with single-photon emission computed tomography study. AJNR Am J Neuroradiol 2005;26:252–257.
15.
Hosoda K, Kawaguchi T, Ishii K, Minoshima S, Shibata Y, Iwakura M, Ishiguro S, Kohmura E: Prediction of hyperperfusion after carotid endarterectomy by brain SPECT analysis with semiquantitative statistical mapping method. Stroke 2003;34:1187–1193.
16.
Ogasawara K, Yukawa H, Kobayashi M, Mikami C, Konno H, Terasaki K, Inoue T, Ogawa A: Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg 2003;99:504–510.
17.
The ECIC Bypass Study Group: Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985;313:1191–1200.
18.
Awad IA, Spetzler RF: Extracranial-intracranial bypass surgery: a critical analysis in light of the International Cooperative Study. Neurosurgery 1986;19:655–664.
19.
Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamadate K, Ogawa A: Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report. Neurosurgery 2005;56:E1380, discussion E1380.
20.
Jinnouchi J, Toyoda K, Inoue T, Fujimoto S, Gotoh S, Yasumori K, Ibayashi S, Iida M, Okada Y: Changes in brain volume 2 years after extracranial-intracranial bypass surgery: a preliminary subanalysis of the Japanese EC-IC trial. Cerebrovasc Dis 2006;22:177–182.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.